MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
an InvestmentWires' Publication
|
|
MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
|
Monday, August 5, 2013 ETF Roundup: Barron's Likes Short-Term Bond ETFs Barrons' Johanna Bennett recommended a few pharmaceutical ETFs for investors looking to get exposure to the industry. The S&P Pharmacuetical index rose 24 percent since the beginning of the year, Bennett pointed out. She suggested investors take a look at BlackRock [profile] iShares US Healthcare ETF and Elect Sector Health Care Select Sector SPDR Fund, State Street Bank & Trust [profile] SPDR S&P Pharmaceuticals ETF, Invesco [profile] PowerShares Dynamic Pharmaceuticals Portfolio and iShares US Pharmaceuticals ETF. Bond investors are turning to ultra-short-term bond ETFs now that interest rates are going up, Barrons' Chris Dieterich writes. Vanguard [profile] Short-term Bond, which raked in $3.7 billion brought in the most bond ETF flows and iShares Short Treasury Bond ETF doubled in size so far this year, Dieterich reports. To read more, click here and here. Printed from: MFWire.com/story.asp?s=45290 Copyright 2013, InvestmentWires, Inc. All Rights Reserved |